Literature DB >> 32008177

The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.

Xiaofeng Gong1, Danyu Du1, Yanran Deng1, Yuqi Zhou1, Li Sun1, Shengtao Yuan2.   

Abstract

E3 ligases are a class of critical enzymes that can catalyse the transfer of ubiquitin (Ub) from an E2 enzyme to the substrate and are essential to cellular processes. The E3 ligase HUWE1 (also known as ARF-BP1, HECTH9, HSPC272, Ib772, LASU1, MULE, URE-B1, UREB1, and HECT, UBA and WWE domain-containing E3 ubiquitin protein ligase 1) is encoded by the huwe1 gene. HUWE1 is a key regulator of the DNA damage response, transcription, autophagy, apoptosis and metabolism in a variety of cancers. Due to its pivotal role in conferring substrate specificity, HUWE1 has attracted enormous attention as a promising anticancer drug target. In this review, we indicate the specific molecular structure of HUWE1 and its role in various cellular signalling pathways and highlight new insights into HUWE1 in cancer. Finally, we discuss outstanding questions regarding HUWE1 in oncology and highlight its limitations in drug development and clinical guidance to better define the role of HUWE1 in multiple cancers.

Entities:  

Keywords:  Cancer therapeutics; Drug discovery; HUWE1; Ubiquitination

Year:  2020        PMID: 32008177     DOI: 10.1007/s10637-020-00894-6

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  61 in total

1.  Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1.

Authors:  Steffi Herold; Andreas Hock; Barbara Herkert; Katrien Berns; Jasper Mullenders; Roderick Beijersbergen; Rene Bernards; Martin Eilers
Journal:  EMBO J       Date:  2008-10-16       Impact factor: 11.598

Review 2.  Ubiquitin and ubiquitin-like proteins as multifunctional signals.

Authors:  Rebecca L Welchman; Colin Gordon; R John Mayer
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

3.  The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.

Authors: 
Journal:  Cancer Discov       Date:  2013-06-06       Impact factor: 39.397

4.  A landscape of driver mutations in melanoma.

Authors:  Eran Hodis; Ian R Watson; Gregory V Kryukov; Stefan T Arold; Marcin Imielinski; Jean-Philippe Theurillat; Elizabeth Nickerson; Daniel Auclair; Liren Li; Chelsea Place; Daniel Dicara; Alex H Ramos; Michael S Lawrence; Kristian Cibulskis; Andrey Sivachenko; Douglas Voet; Gordon Saksena; Nicolas Stransky; Robert C Onofrio; Wendy Winckler; Kristin Ardlie; Nikhil Wagle; Jennifer Wargo; Kelly Chong; Donald L Morton; Katherine Stemke-Hale; Guo Chen; Michael Noble; Matthew Meyerson; John E Ladbury; Michael A Davies; Jeffrey E Gershenwald; Stephan N Wagner; Dave S B Hoon; Dirk Schadendorf; Eric S Lander; Stacey B Gabriel; Gad Getz; Levi A Garraway; Lynda Chin
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

5.  Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production.

Authors:  Lei Gong; Bo Yang; Ming Xu; Bo Cheng; Xuejun Tang; Ping Zheng; Yan Jing; Gao-jue Wu
Journal:  Cancer Chemother Pharmacol       Date:  2013-11-05       Impact factor: 3.333

6.  Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage.

Authors:  Jonathan R Hall; Evelyn Kow; Kathleen R Nevis; Chiajung Karen Lu; K Scott Luce; Qing Zhong; Jeanette Gowen Cook
Journal:  Mol Biol Cell       Date:  2007-06-13       Impact factor: 4.138

7.  Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation.

Authors:  Ping Xu; Duc M Duong; Nicholas T Seyfried; Dongmei Cheng; Yang Xie; Jessica Robert; John Rush; Mark Hochstrasser; Daniel Finley; Junmin Peng
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

8.  An integrated bioinformatics platform for investigating the human E3 ubiquitin ligase-substrate interaction network.

Authors:  Yang Li; Ping Xie; Liang Lu; Jian Wang; Lihong Diao; Zhongyang Liu; Feifei Guo; Yangzhige He; Yuan Liu; Qin Huang; Han Liang; Dong Li; Fuchu He
Journal:  Nat Commun       Date:  2017-08-24       Impact factor: 14.919

9.  System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes.

Authors:  Wei Zhang; Kuen-Phon Wu; Maria A Sartori; Hari B Kamadurai; Alban Ordureau; Chong Jiang; Peter Y Mercredi; Ryan Murchie; Jicheng Hu; Avinash Persaud; Manjeet Mukherjee; Nan Li; Anne Doye; John R Walker; Yi Sheng; Zhenyue Hao; Yanjun Li; Kevin R Brown; Emmanuel Lemichez; Junjie Chen; Yufeng Tong; J Wade Harper; Jason Moffat; Daniela Rotin; Brenda A Schulman; Sachdev S Sidhu
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

10.  The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells.

Authors:  Bryan King; Francesco Boccalatte; Kelly Moran-Crusio; Elmar Wolf; Jingjing Wang; Clarisse Kayembe; Charalampos Lazaris; Xiaofeng Yu; Beatriz Aranda-Orgilles; Anna Lasorella; Iannis Aifantis
Journal:  Nat Immunol       Date:  2016-09-26       Impact factor: 25.606

View more
  10 in total

1.  SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1.

Authors:  Katie L Pennington; Colten M McEwan; James Woods; Colin M Muir; A G Pramoda Sahankumari; Riley Eastmond; Eranga R Balasooriya; Christina M Egbert; Sandeep Kaur; Tyler Heaton; Katherine K McCormack; Stephen R Piccolo; Manabu Kurokawa; Joshua L Andersen
Journal:  Mol Cancer Res       Date:  2021-10-15       Impact factor: 6.333

2.  Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling.

Authors:  Chen Hang; Shanojie Zhao; Tiejun Wang; Yan Zhang
Journal:  Cancer Cell Int       Date:  2021-01-06       Impact factor: 5.722

3.  A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.

Authors:  Yahya Benslimane; María Sánchez-Osuna; Jasmin Coulombe-Huntington; Thierry Bertomeu; Danielle Henry; Caroline Huard; Éric Bonneil; Pierre Thibault; Mike Tyers; Lea Harrington
Journal:  Aging Cell       Date:  2021-03-04       Impact factor: 9.304

4.  HUWE1 Causes an Immune Imbalance in Immune Thrombocytopenic Purpura by Reducing the Number and Function of Treg Cells Through the Ubiquitination Degradation of Ets-1.

Authors:  Jianqin Li; Yalin Xia; Xiaoru Fan; Xiaofang Wu; Feiyun Yang; Shaoyan Hu; Zhaoyue Wang
Journal:  Front Cell Dev Biol       Date:  2021-11-25

5.  Inhibition of cotranslational translocation by apratoxin S4: Effects on oncogenic receptor tyrosine kinases and the fate of transmembrane proteins produced in the cytoplasm.

Authors:  Weijing Cai; Ranjala Ratnayake; Mengxiong Wang; Qi-Yin Chen; Kevin P Raisch; Long H Dang; Brian K Law; Hendrik Luesch
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-09-08

6.  Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma.

Authors:  Yibo Ma; Changgui Tong; Mingjun Xu; Hongtao He; Changjian Chen
Journal:  J Oncol       Date:  2022-07-14       Impact factor: 4.501

Review 7.  The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases.

Authors:  Lu Qi; Xiaoqing Xu; Xiaopeng Qi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

8.  C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways.

Authors:  David R Amici; Daniel J Ansel; Kyle A Metz; Roger S Smith; Claire M Phoumyvong; Sitaram Gayatri; Tomasz Chamera; Stacey L Edwards; Brendan P O'Hara; Shashank Srivastava; Sonia Brockway; Seesha R Takagishi; Byoung-Kyu Cho; Young Ah Goo; Neil L Kelleher; Issam Ben-Sahra; Daniel R Foltz; Jian Li; Marc L Mendillo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-01       Impact factor: 12.779

9.  Polyclonal evolution of Fanconi anemia to MDS and AML revealed at single cell resolution.

Authors:  Lixian Chang; Zejia Cui; Deyang Shi; Yajing Chu; Bichen Wang; Yang Wan; Qiuyi Ma; Ranran Zhang; Haoyuan Li; Xuelian Cheng; Tao Cheng; Xiaofan Zhu; Cheng Li; Weiping Yuan
Journal:  Exp Hematol Oncol       Date:  2022-09-27

Review 10.  A Potential Role for HUWE1 in Modulating Cisplatin Sensitivity.

Authors:  Stijn Wenmaekers; Bastiaan J Viergever; Gunjan Kumar; Onno Kranenburg; Peter C Black; Mads Daugaard; Richard P Meijer
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.